Lupin acquires two diabetes brands from Boehringer Ingelheim
Lupin on Friday mentioned it has acquired diabetes manufacturers Ondero (linagliptin) and Ondero Met (linagliptin and metformin) from Boehringer Ingelheim ...
Lupin on Friday mentioned it has acquired diabetes manufacturers Ondero (linagliptin) and Ondero Met (linagliptin and metformin) from Boehringer Ingelheim ...
German drug maker Boehringer Ingelheim (BI) on Thursday mentioned it has obtained approval from the Central Medicine Normal Management Organisation ...
Copyright © 2022 Asia Today.